Holen Sie sich die Stockscreener-App
2.84
6.17%
0.165
Vorhandelsmarkt:
2.77
-0.07
-2.46%
Schlusskurs vom Vortag:
$2.675
Offen:
$2.735
24-Stunden-Volumen:
60,831
Relative Volume:
0.34
Marktkapitalisierung:
$2.56M
Einnahmen:
$8.97M
Nettoeinkommen (Verlust:
$-15.21M
KGV:
-0.0244
EPS:
-116.51
Netto-Cashflow:
$-10.84M
1W Leistung:
+21.37%
1M Leistung:
+4.80%
6M Leistung:
+1,113%
1J Leistung:
+111.94%
1-Tages-Spanne:
$2.68
$2.86
1-Wochen-Bereich:
$2.40
$2.86
52-Wochen-Spanne:
$0.19
$25.95
Nuwellis Inc Stock (NUWE) Company Profile
Firmenname
Nuwellis Inc
Sektor
Branche
Telefon
952-345-4200
Adresse
12988 VALLEY VIEW ROAD, EDEN PRAIRIE
Vergleichen Sie NUWE mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
NUWE
Nuwellis Inc
|
2.84 | 2.41M | 8.97M | -15.21M | -10.84M | -116.51 |
|
ABT
Abbott Laboratories
|
122.55 | 210.84B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
92.70 | 137.17B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
353.80 | 133.55B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
100.77 | 127.71B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
83.92 | 48.33B | 5.88B | 1.34B | 799.60M | 2.3489 |
Nuwellis Inc Stock (NUWE) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-07-29 | Eingeleitet | ROTH MKM | Buy |
Nuwellis Inc Aktie (NUWE) Neueste Nachrichten
Nuwellis, Inc. Announces the Presentation of New Real-World Data from New York City's Lenox Hill Hospital at the 2025 American Society of Nephrology Kidney Week - marketscreener.com
Nuwellis Stock Jump Looks Great, But How Secure Is That Gain? - Trefis
Nuwellis (NUWE) Reveals Promising Data on Aquadex Therapy at ASN Kidney Week 2025 - GuruFocus
Lenox Hill Hospital Study Highlights the Broad Utility of Aquadex in Managing Fluid Overload Across Critical Care Settings - The Manila Times
Nuwellis, Inc. Showcases Real-World Data on Aquadex® Therapy for Acute Kidney Injury at ASN Kidney Week 2025 - Quiver Quantitative
Nuwellis (Nasdaq: NUWE) Aquadex Study of 69 Lenox Hill Cases Backs AKI Care Practice - Stock Titan
Would You Still Hold Nuwellis Stock If It Fell Another 30%? - Trefis
With Nuwellis Stock Sliding, Have You Assessed The Risk? - Trefis
Nuwellis Stock Drop Looks Sharp, But How Deep Can It Go? - Trefis
How Nuwellis Inc. stock compares to market leadersWeekly Profit Analysis & Free Daily Entry Point Trade Alerts - Newser
Nuwellis expands pediatric presence with new children’s hospital adoption By Investing.com - Investing.com Nigeria
Nuwellis (NUWE) Expands with New Aquadex Program in Northeastern Children's Hospital - GuruFocus
Nuwellis expands pediatric presence with new children’s hospital adoption - Investing.com
Nuwellis Continues Clinician-Driven Growth in Pediatric Care with a Leading Hospital in the Northeast U.S. - The Manila Times
Nuwellis (Nasdaq: NUWE) grows clinician-led Aquadex adoption in U.S. pediatric hospitals - Stock Titan
Is Nuwellis Stock Built to Withstand More Downside? - Trefis
How does Nuwellis Inc (NUWE) change from a tortoise to a hare? - Setenews
Nuwellis (NUWE) Gets a Hold from Maxim Group - The Globe and Mail
Is Nuwellis Inc. stock a buy on dips2025 Investor Takeaways & Expert Verified Movement Alerts - newser.com
Maxim Group Maintains Nuwellis(NUWE.US) With Hold Rating, Announces Target Price $3.9 - 富途牛牛
Will Nuwellis Inc. stock benefit from commodity pricesRate Hike & Low Risk Investment Opportunities - newser.com
Will Nuwellis Inc. stock benefit from green energy trendsTrade Exit Report & Verified Short-Term Trading Plans - newser.com
Comparing Nuwellis Inc. in custom built stock radarsQuarterly Profit Summary & Long-Term Capital Growth Ideas - newser.com
What candlestick patterns are forming on Nuwellis Inc.Trade Risk Report & AI Based Buy and Sell Signals - newser.com
Developing predictive dashboards with Nuwellis Inc. dataPortfolio Performance Report & Long-Term Capital Growth Strategies - newser.com
Nuwellis receives notice of allowance for U.S. patent on Vivian system - MSN
Can swing trading help recover from Nuwellis Inc. lossesQuarterly Portfolio Review & Breakout Confirmation Trade Signals - newser.com
Nuwellis Reports Q3 2025 Results and Strategic Advances - TipRanks
Earnings call transcript: Nuwellis Q3 2025 reveals revenue decline, stock dips - Investing.com Nigeria
Nuwellis Inc (NUWE) Q3 2025 Earnings Call Highlights: Strong Seq - GuruFocus
[10-Q] Nuwellis, Inc. Quarterly Earnings Report | NUWE SEC FilingForm 10-Q - Stock Titan
Nuwellis Inc (NUWE) Q3 2025 Earnings Call Highlights: Strong Sequential Growth Amid Revenue ... - Yahoo Finance
Nuwellis Q3 2025 Earnings Call Transcript - MarketBeat
Nuwellis Q3 Earnings Preview - MSN
Nuwellis Reports Third Quarter 2025 Results and Continued Operational Momentum - The Manila Times
Medical tech firm Nuwellis Q3 revenue down 6% yr/yr - MarketScreener
Nuwellis, Inc. Reports Third Quarter 2025 Financial Results and Strategic Milestones - Quiver Quantitative
Nuwellis (NASDAQ: NUWE) posts $2.2M Q3 revenue; pro-forma up 7% YoY, on U.S. strength - Stock Titan
Finanzdaten der Nuwellis Inc-Aktie (NUWE)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.34%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):